This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Anatomy of an M&A Transaction: How to Issue Spot for Non-Compete, Trade Secrets/Confidential Information, and Intellectual Capital Concerns. It is only by keeping up with the newest laws and court pronouncements that litigants can hope to prevail in this ever-changing landscape.
On 14-16 March, this GuestKat had the opportunity to attend the "Pharma & Biotech Patent Litigation" conference in Amsterdam, which, as many readers will know, not only hosts the Kattenkabinet museum (here below a sample of the oeuvres of the museum.), but it’s also an important IP and Life Sciences hub.
Anatomy of an M&A Transaction: How to Issue Spot for Non-Compete, Trade Secrets/Confidential Information, and Intellectual Capital Concerns. It is only by keeping up with the newest laws and court pronouncements that litigants can hope to prevail in this ever-changing landscape.
Protecting Confidential Information and Client Relationships in the Financial Services Industry. Anatomy of a Restrictive Covenant. How and Why Texas Is Different When It Comes to Trade Secrets and Non-Competes. How Multijurisdictional Businesses Should Approach Non-Competes.
The Federal Trade Commission (FTC) and the Department of Justice (DOJ) hosted a virtual workshop on December 6-7, 2021, bringing together agency representatives, lawyers, economists, academics, and other experts to discuss issues affecting competition in the labor market (“Workshop”). Takeaways from the Workshop.
Protecting Confidential Information and Client Relationships in the Financial Services Industry. Anatomy of a Restrictive Covenant. How and Why Texas Is Different When It Comes to Trade Secrets and Non-Competes. How Multijurisdictional Businesses Should Approach Non-Competes.
.” Noteworthy Trade Secret Discovery Opinions: The forensic review of a former employee or business partner’s computer is one of the most intrusive and contentious discovery procedures in trade secret litigation. Litigation Funders Beware! Want to persuade a litigation funder to help you with your trade secrets case?
On January 9, 2020, the FTC held a public workshop to consider whether the FTC should issue a rule that would limit or forbid the use of non-competes in employment contracts and subsequently invited submissions from interested parties. Smaller companies therefore rely on non-competes to better protect themselves in these cases.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content